Synthesis and basic evaluation of 7α-(3-[18F]fluoropropyl)-testosterone and 7α-(3-[18F]fluoropropyl)-dihydrotestosterone

Objective 7α-Substituted androgen derivatives may have the potential to visualize androgen receptors with positron emission tomography. In the present study, we synthesized fluoropropyl derivatives of 7α-(3-[ 18 F]fluoropropyl)-testosterone ([ 18 F] 7 ) and 7α-(3-[ 18 F]fluoropropyl)-dihydrotestoste...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of nuclear medicine 2017, Vol.31 (1), p.53-62
Hauptverfasser: Okamoto, Mayumi, Naka, Kyosuke, Ishiwata, Kiichi, Shimizu, Isao, Toyohara, Jun
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 62
container_issue 1
container_start_page 53
container_title Annals of nuclear medicine
container_volume 31
creator Okamoto, Mayumi
Naka, Kyosuke
Ishiwata, Kiichi
Shimizu, Isao
Toyohara, Jun
description Objective 7α-Substituted androgen derivatives may have the potential to visualize androgen receptors with positron emission tomography. In the present study, we synthesized fluoropropyl derivatives of 7α-(3-[ 18 F]fluoropropyl)-testosterone ([ 18 F] 7 ) and 7α-(3-[ 18 F]fluoropropyl)-dihydrotestosterone ([ 18 F] 15 ), and characterized their in vitro binding, in vivo biodistribution, and performed blocking studies in mature androgen deprived male rats. Methods We synthesized [ 18 F] 7 and [ 18 F] 15 . In vitro binding to recombinant rat AR ligand binding domain protein was determined using a competitive radiometric ligand-binding assay with the high-affinity synthetic androgen [17α-methyl- 3 H]-methyltrienolone ([ 3 H]R1881). In vivo biodistribution was performed in mature male rats treated with diethylstilbestrol (chemical castration). A blocking study was performed by co-administration of dihydrotestosterone (36 µg/animal). Results 7α-(3-Fluoropropyl)-testosterone ( 7 ) and 7α-(3-fluoropropyl)-dihydrotestosterone ( 15 ) showed competitive binding to recombinant rat AR ligand binding domain protein. The IC 50 value of 15 (13.0 ± 3.3 nM) was higher than 7 (47.8 ± 10.0 nM). In contrast to the AR binding affinity, the ventral prostate uptake of [ 18 F] 7 and [ 18 F] 15 at 2 h post-injection was similar (0.07 % injected dose/g of tissue). A blocking study indicated that specific binding of [ 18 F] 15 is observed in the ventral prostate. [ 18 F] 7 and [ 18 F] 15 showed moderate levels of bone uptake, which indicates moderate metabolic de-fluorination in rodents. Conclusion [ 18 F] 15 is better than [ 18 F] 7 in terms of radiochemical yield, in vitro binding affinity, prostate specific binding and stability against in vivo metabolic de-fluorination. However, the net uptake level of [ 18 F] 15 in prostate might be insufficient for in vivo visualization. Although [ 18 F] 7 and [ 18 F] 15 improved in vivo stability against de-fluorination, other basic characterization data in rodents were not superior to the current standard tracer 16β-[ 18 F]fluoro-5α-dihydrotestosterone. It is also revealed that the shorter side chain length of 7α-[ 18 F]fluoromethyl-dihydrotestosterone is superior to the longer three carbon chain in [ 18 F] 15 , in terms of net prostate uptake and in vivo metabolic stability.
doi_str_mv 10.1007/s12149-016-1130-7
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1859737944</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1859737944</sourcerecordid><originalsourceid>FETCH-LOGICAL-c320t-cd09b0342e3c00d037e04b34254db51adefce9a6e81089e9e14f3da4cede756a3</originalsourceid><addsrcrecordid>eNp9kM1O3DAURi1UxAw_D9ANynJYuNwbO7GzRKNSKiGxAFaospz4pgRl4sFOKg1vxYvwTDUdWrGhkiXryuf7dH0Y-4zwBQHUacQcZcUBS44ogKsdNkddSl5KIT6xOVQouUKtZmw_xgeAXBc632OzXJU6TfmcPV1vhvGeYhczO7istrFrMvpl-8mOnR8y32bq5ZkvBL9Dff6j7Scf_DqdTX_CR4qjjyMFP9Cf-Meo6-43Lvj3iUO229o-0tHbfcBuz7_eLC_45dW378uzS96IHEbeOKhqEDIn0QA4EIpA1mkupKsLtI7ahipbkkbQFVWEshXOyoYcqaK04oAttr1pl8cpLWBWXWyo7-1AfooGdVEpoSopE4pbtAk-xkCtWYduZcPGIJhX5War3CTl5lW5USlz_FY_1Sty_xJ_HScg3wIxPQ0_KZgHP4Uhffk_rb8BCfCO6g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1859737944</pqid></control><display><type>article</type><title>Synthesis and basic evaluation of 7α-(3-[18F]fluoropropyl)-testosterone and 7α-(3-[18F]fluoropropyl)-dihydrotestosterone</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Okamoto, Mayumi ; Naka, Kyosuke ; Ishiwata, Kiichi ; Shimizu, Isao ; Toyohara, Jun</creator><creatorcontrib>Okamoto, Mayumi ; Naka, Kyosuke ; Ishiwata, Kiichi ; Shimizu, Isao ; Toyohara, Jun</creatorcontrib><description>Objective 7α-Substituted androgen derivatives may have the potential to visualize androgen receptors with positron emission tomography. In the present study, we synthesized fluoropropyl derivatives of 7α-(3-[ 18 F]fluoropropyl)-testosterone ([ 18 F] 7 ) and 7α-(3-[ 18 F]fluoropropyl)-dihydrotestosterone ([ 18 F] 15 ), and characterized their in vitro binding, in vivo biodistribution, and performed blocking studies in mature androgen deprived male rats. Methods We synthesized [ 18 F] 7 and [ 18 F] 15 . In vitro binding to recombinant rat AR ligand binding domain protein was determined using a competitive radiometric ligand-binding assay with the high-affinity synthetic androgen [17α-methyl- 3 H]-methyltrienolone ([ 3 H]R1881). In vivo biodistribution was performed in mature male rats treated with diethylstilbestrol (chemical castration). A blocking study was performed by co-administration of dihydrotestosterone (36 µg/animal). Results 7α-(3-Fluoropropyl)-testosterone ( 7 ) and 7α-(3-fluoropropyl)-dihydrotestosterone ( 15 ) showed competitive binding to recombinant rat AR ligand binding domain protein. The IC 50 value of 15 (13.0 ± 3.3 nM) was higher than 7 (47.8 ± 10.0 nM). In contrast to the AR binding affinity, the ventral prostate uptake of [ 18 F] 7 and [ 18 F] 15 at 2 h post-injection was similar (0.07 % injected dose/g of tissue). A blocking study indicated that specific binding of [ 18 F] 15 is observed in the ventral prostate. [ 18 F] 7 and [ 18 F] 15 showed moderate levels of bone uptake, which indicates moderate metabolic de-fluorination in rodents. Conclusion [ 18 F] 15 is better than [ 18 F] 7 in terms of radiochemical yield, in vitro binding affinity, prostate specific binding and stability against in vivo metabolic de-fluorination. However, the net uptake level of [ 18 F] 15 in prostate might be insufficient for in vivo visualization. Although [ 18 F] 7 and [ 18 F] 15 improved in vivo stability against de-fluorination, other basic characterization data in rodents were not superior to the current standard tracer 16β-[ 18 F]fluoro-5α-dihydrotestosterone. It is also revealed that the shorter side chain length of 7α-[ 18 F]fluoromethyl-dihydrotestosterone is superior to the longer three carbon chain in [ 18 F] 15 , in terms of net prostate uptake and in vivo metabolic stability.</description><identifier>ISSN: 0914-7187</identifier><identifier>EISSN: 1864-6433</identifier><identifier>DOI: 10.1007/s12149-016-1130-7</identifier><identifier>PMID: 27680022</identifier><language>eng</language><publisher>Tokyo: Springer Japan</publisher><subject>Androgens - deficiency ; Animals ; Chemistry Techniques, Synthetic ; Dihydrotestosterone - chemical synthesis ; Dihydrotestosterone - chemistry ; Dihydrotestosterone - metabolism ; Dihydrotestosterone - pharmacokinetics ; Imaging ; Male ; Medicine ; Medicine &amp; Public Health ; Nuclear Medicine ; Original Article ; Radiochemistry ; Radiology ; Rats ; Receptors, Androgen - metabolism ; Testosterone - analogs &amp; derivatives ; Testosterone - chemical synthesis ; Testosterone - chemistry ; Testosterone - metabolism ; Testosterone - pharmacokinetics ; Tissue Distribution</subject><ispartof>Annals of nuclear medicine, 2017, Vol.31 (1), p.53-62</ispartof><rights>The Japanese Society of Nuclear Medicine 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c320t-cd09b0342e3c00d037e04b34254db51adefce9a6e81089e9e14f3da4cede756a3</cites><orcidid>0000-0003-4721-405X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12149-016-1130-7$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12149-016-1130-7$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27680022$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Okamoto, Mayumi</creatorcontrib><creatorcontrib>Naka, Kyosuke</creatorcontrib><creatorcontrib>Ishiwata, Kiichi</creatorcontrib><creatorcontrib>Shimizu, Isao</creatorcontrib><creatorcontrib>Toyohara, Jun</creatorcontrib><title>Synthesis and basic evaluation of 7α-(3-[18F]fluoropropyl)-testosterone and 7α-(3-[18F]fluoropropyl)-dihydrotestosterone</title><title>Annals of nuclear medicine</title><addtitle>Ann Nucl Med</addtitle><addtitle>Ann Nucl Med</addtitle><description>Objective 7α-Substituted androgen derivatives may have the potential to visualize androgen receptors with positron emission tomography. In the present study, we synthesized fluoropropyl derivatives of 7α-(3-[ 18 F]fluoropropyl)-testosterone ([ 18 F] 7 ) and 7α-(3-[ 18 F]fluoropropyl)-dihydrotestosterone ([ 18 F] 15 ), and characterized their in vitro binding, in vivo biodistribution, and performed blocking studies in mature androgen deprived male rats. Methods We synthesized [ 18 F] 7 and [ 18 F] 15 . In vitro binding to recombinant rat AR ligand binding domain protein was determined using a competitive radiometric ligand-binding assay with the high-affinity synthetic androgen [17α-methyl- 3 H]-methyltrienolone ([ 3 H]R1881). In vivo biodistribution was performed in mature male rats treated with diethylstilbestrol (chemical castration). A blocking study was performed by co-administration of dihydrotestosterone (36 µg/animal). Results 7α-(3-Fluoropropyl)-testosterone ( 7 ) and 7α-(3-fluoropropyl)-dihydrotestosterone ( 15 ) showed competitive binding to recombinant rat AR ligand binding domain protein. The IC 50 value of 15 (13.0 ± 3.3 nM) was higher than 7 (47.8 ± 10.0 nM). In contrast to the AR binding affinity, the ventral prostate uptake of [ 18 F] 7 and [ 18 F] 15 at 2 h post-injection was similar (0.07 % injected dose/g of tissue). A blocking study indicated that specific binding of [ 18 F] 15 is observed in the ventral prostate. [ 18 F] 7 and [ 18 F] 15 showed moderate levels of bone uptake, which indicates moderate metabolic de-fluorination in rodents. Conclusion [ 18 F] 15 is better than [ 18 F] 7 in terms of radiochemical yield, in vitro binding affinity, prostate specific binding and stability against in vivo metabolic de-fluorination. However, the net uptake level of [ 18 F] 15 in prostate might be insufficient for in vivo visualization. Although [ 18 F] 7 and [ 18 F] 15 improved in vivo stability against de-fluorination, other basic characterization data in rodents were not superior to the current standard tracer 16β-[ 18 F]fluoro-5α-dihydrotestosterone. It is also revealed that the shorter side chain length of 7α-[ 18 F]fluoromethyl-dihydrotestosterone is superior to the longer three carbon chain in [ 18 F] 15 , in terms of net prostate uptake and in vivo metabolic stability.</description><subject>Androgens - deficiency</subject><subject>Animals</subject><subject>Chemistry Techniques, Synthetic</subject><subject>Dihydrotestosterone - chemical synthesis</subject><subject>Dihydrotestosterone - chemistry</subject><subject>Dihydrotestosterone - metabolism</subject><subject>Dihydrotestosterone - pharmacokinetics</subject><subject>Imaging</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Nuclear Medicine</subject><subject>Original Article</subject><subject>Radiochemistry</subject><subject>Radiology</subject><subject>Rats</subject><subject>Receptors, Androgen - metabolism</subject><subject>Testosterone - analogs &amp; derivatives</subject><subject>Testosterone - chemical synthesis</subject><subject>Testosterone - chemistry</subject><subject>Testosterone - metabolism</subject><subject>Testosterone - pharmacokinetics</subject><subject>Tissue Distribution</subject><issn>0914-7187</issn><issn>1864-6433</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM1O3DAURi1UxAw_D9ANynJYuNwbO7GzRKNSKiGxAFaospz4pgRl4sFOKg1vxYvwTDUdWrGhkiXryuf7dH0Y-4zwBQHUacQcZcUBS44ogKsdNkddSl5KIT6xOVQouUKtZmw_xgeAXBc632OzXJU6TfmcPV1vhvGeYhczO7istrFrMvpl-8mOnR8y32bq5ZkvBL9Dff6j7Scf_DqdTX_CR4qjjyMFP9Cf-Meo6-43Lvj3iUO229o-0tHbfcBuz7_eLC_45dW378uzS96IHEbeOKhqEDIn0QA4EIpA1mkupKsLtI7ahipbkkbQFVWEshXOyoYcqaK04oAttr1pl8cpLWBWXWyo7-1AfooGdVEpoSopE4pbtAk-xkCtWYduZcPGIJhX5War3CTl5lW5USlz_FY_1Sty_xJ_HScg3wIxPQ0_KZgHP4Uhffk_rb8BCfCO6g</recordid><startdate>2017</startdate><enddate>2017</enddate><creator>Okamoto, Mayumi</creator><creator>Naka, Kyosuke</creator><creator>Ishiwata, Kiichi</creator><creator>Shimizu, Isao</creator><creator>Toyohara, Jun</creator><general>Springer Japan</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4721-405X</orcidid></search><sort><creationdate>2017</creationdate><title>Synthesis and basic evaluation of 7α-(3-[18F]fluoropropyl)-testosterone and 7α-(3-[18F]fluoropropyl)-dihydrotestosterone</title><author>Okamoto, Mayumi ; Naka, Kyosuke ; Ishiwata, Kiichi ; Shimizu, Isao ; Toyohara, Jun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c320t-cd09b0342e3c00d037e04b34254db51adefce9a6e81089e9e14f3da4cede756a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Androgens - deficiency</topic><topic>Animals</topic><topic>Chemistry Techniques, Synthetic</topic><topic>Dihydrotestosterone - chemical synthesis</topic><topic>Dihydrotestosterone - chemistry</topic><topic>Dihydrotestosterone - metabolism</topic><topic>Dihydrotestosterone - pharmacokinetics</topic><topic>Imaging</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Nuclear Medicine</topic><topic>Original Article</topic><topic>Radiochemistry</topic><topic>Radiology</topic><topic>Rats</topic><topic>Receptors, Androgen - metabolism</topic><topic>Testosterone - analogs &amp; derivatives</topic><topic>Testosterone - chemical synthesis</topic><topic>Testosterone - chemistry</topic><topic>Testosterone - metabolism</topic><topic>Testosterone - pharmacokinetics</topic><topic>Tissue Distribution</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Okamoto, Mayumi</creatorcontrib><creatorcontrib>Naka, Kyosuke</creatorcontrib><creatorcontrib>Ishiwata, Kiichi</creatorcontrib><creatorcontrib>Shimizu, Isao</creatorcontrib><creatorcontrib>Toyohara, Jun</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of nuclear medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Okamoto, Mayumi</au><au>Naka, Kyosuke</au><au>Ishiwata, Kiichi</au><au>Shimizu, Isao</au><au>Toyohara, Jun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and basic evaluation of 7α-(3-[18F]fluoropropyl)-testosterone and 7α-(3-[18F]fluoropropyl)-dihydrotestosterone</atitle><jtitle>Annals of nuclear medicine</jtitle><stitle>Ann Nucl Med</stitle><addtitle>Ann Nucl Med</addtitle><date>2017</date><risdate>2017</risdate><volume>31</volume><issue>1</issue><spage>53</spage><epage>62</epage><pages>53-62</pages><issn>0914-7187</issn><eissn>1864-6433</eissn><abstract>Objective 7α-Substituted androgen derivatives may have the potential to visualize androgen receptors with positron emission tomography. In the present study, we synthesized fluoropropyl derivatives of 7α-(3-[ 18 F]fluoropropyl)-testosterone ([ 18 F] 7 ) and 7α-(3-[ 18 F]fluoropropyl)-dihydrotestosterone ([ 18 F] 15 ), and characterized their in vitro binding, in vivo biodistribution, and performed blocking studies in mature androgen deprived male rats. Methods We synthesized [ 18 F] 7 and [ 18 F] 15 . In vitro binding to recombinant rat AR ligand binding domain protein was determined using a competitive radiometric ligand-binding assay with the high-affinity synthetic androgen [17α-methyl- 3 H]-methyltrienolone ([ 3 H]R1881). In vivo biodistribution was performed in mature male rats treated with diethylstilbestrol (chemical castration). A blocking study was performed by co-administration of dihydrotestosterone (36 µg/animal). Results 7α-(3-Fluoropropyl)-testosterone ( 7 ) and 7α-(3-fluoropropyl)-dihydrotestosterone ( 15 ) showed competitive binding to recombinant rat AR ligand binding domain protein. The IC 50 value of 15 (13.0 ± 3.3 nM) was higher than 7 (47.8 ± 10.0 nM). In contrast to the AR binding affinity, the ventral prostate uptake of [ 18 F] 7 and [ 18 F] 15 at 2 h post-injection was similar (0.07 % injected dose/g of tissue). A blocking study indicated that specific binding of [ 18 F] 15 is observed in the ventral prostate. [ 18 F] 7 and [ 18 F] 15 showed moderate levels of bone uptake, which indicates moderate metabolic de-fluorination in rodents. Conclusion [ 18 F] 15 is better than [ 18 F] 7 in terms of radiochemical yield, in vitro binding affinity, prostate specific binding and stability against in vivo metabolic de-fluorination. However, the net uptake level of [ 18 F] 15 in prostate might be insufficient for in vivo visualization. Although [ 18 F] 7 and [ 18 F] 15 improved in vivo stability against de-fluorination, other basic characterization data in rodents were not superior to the current standard tracer 16β-[ 18 F]fluoro-5α-dihydrotestosterone. It is also revealed that the shorter side chain length of 7α-[ 18 F]fluoromethyl-dihydrotestosterone is superior to the longer three carbon chain in [ 18 F] 15 , in terms of net prostate uptake and in vivo metabolic stability.</abstract><cop>Tokyo</cop><pub>Springer Japan</pub><pmid>27680022</pmid><doi>10.1007/s12149-016-1130-7</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0003-4721-405X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0914-7187
ispartof Annals of nuclear medicine, 2017, Vol.31 (1), p.53-62
issn 0914-7187
1864-6433
language eng
recordid cdi_proquest_miscellaneous_1859737944
source MEDLINE; SpringerNature Journals
subjects Androgens - deficiency
Animals
Chemistry Techniques, Synthetic
Dihydrotestosterone - chemical synthesis
Dihydrotestosterone - chemistry
Dihydrotestosterone - metabolism
Dihydrotestosterone - pharmacokinetics
Imaging
Male
Medicine
Medicine & Public Health
Nuclear Medicine
Original Article
Radiochemistry
Radiology
Rats
Receptors, Androgen - metabolism
Testosterone - analogs & derivatives
Testosterone - chemical synthesis
Testosterone - chemistry
Testosterone - metabolism
Testosterone - pharmacokinetics
Tissue Distribution
title Synthesis and basic evaluation of 7α-(3-[18F]fluoropropyl)-testosterone and 7α-(3-[18F]fluoropropyl)-dihydrotestosterone
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T15%3A29%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20basic%20evaluation%20of%207%CE%B1-(3-%5B18F%5Dfluoropropyl)-testosterone%20and%207%CE%B1-(3-%5B18F%5Dfluoropropyl)-dihydrotestosterone&rft.jtitle=Annals%20of%20nuclear%20medicine&rft.au=Okamoto,%20Mayumi&rft.date=2017&rft.volume=31&rft.issue=1&rft.spage=53&rft.epage=62&rft.pages=53-62&rft.issn=0914-7187&rft.eissn=1864-6433&rft_id=info:doi/10.1007/s12149-016-1130-7&rft_dat=%3Cproquest_cross%3E1859737944%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1859737944&rft_id=info:pmid/27680022&rfr_iscdi=true